The effect of kavaine and magnesium orotate combination in the psycho - organic disorders of the elderly.
D000368:Aged; D003704:Dementia / Q000188:drug therapy*; D004338:Drug Combinations / Q000627:therapeutic use; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D009963:Orotic Acid / Q000627:therapeutic use*; D011714:Pyrans / Q000627:therapeutic use*; D011753:Pyrones / Q000627:therapeutic use*; D012824:Silicic Acid / Q000627:therapeutic use*; D012822:Silicon Dioxide / Q000627:therapeutic use*
D004338:Drug Combinations; D011714:Pyrans; D011753:Pyrones; D012824:Silicic Acid; D009963:Orotic Acid; D012822:Silicon Dioxide; C001497:kavaform